Aortic Regurgitation, Aortic Stenosis, Severe, Aortic Valve Insufficiency, Aortic Valve Stenosis, Coronary; Obstruction, Heart Valve Diseases, Regurgitation, Aortic, Stenoses, Aortic, Valve Disease, Aortic
Conditions
Keywords
Aortic valve replacement, Aortic valve bioprosthesis, Coronary ostia obstruction, Valve-in-valve, Transcatheter aortic valve implantation, Aortic valve stenosis, Tricuspid aortic valve, Aortic valve regurgitation, CT coronary angiogram, Transcatheter aortic valve replacement
Brief summary
The goal of this interventional, single-center study is to demonstrate if there is a change in the coronary ostia height after surgical aortic valve replacement and if it depends on the type of prosthesis or surgical technique used. The study involves patients undergoing elective surgical aortic valve replacement with a bioprosthesis. Participants enrolled will undergo a CT scan before and after surgery (at least 90 days after surgery) to analyze coronary ostia height.
Detailed description
Aortic valve stenosis is the most frequent heart valve disease in the adult population. The development of biological prostheses with slower valve degeneration and easier antithrombotic management and changes in the indications for the treatment of this valve disease, have allowed a reduction in the age in which such prostheses are implanted thus leading to a greater use of biological prostheses rather than mechanical ones. In the next few years this will cause a higher rate of structural valve degeneration resulting in stenosis and/or insufficiency. In patients considered to be at high surgical risk, the transcatheter implantation of a valve-in-valve (VIV) represents a valid alternative to standard surgery, except for coronary obstruction which appears more frequent in VIV procedures, especially in patients receiving VIV after surgical aortic valve replacement. The risk factors mainly associated with this complication are represented by the type of implanted prostheses and the anatomical relationship between the coronary ostia and the expected final position of the cusps of the bioprostheses transcatheter-implanted.Recent studies have demonstrated how coronary height seems to be significantly reduced in case of surgical aortic valve replacement with a supra-annular technique, as occurs in our center. Aim of this interventional, single-center study is to demonstrate whether there is a change in the coronary ostia height after surgical aortic valve replacement and whether it possibly depends on the type of prosthesis. All patients undergoing elective aortic valve replacement surgery at our institution who meet the inclusion criteria for the study will be contacted to perform a postoperative CT scan at least 90 days after surgery.
Interventions
RADIATIONCT scan with contrast medium
Multi-detector CT scan (if possible with prospective-ECG gated sequential scan) with contrast medium injection of nonionic contrast agent. All CT datasets will be analysed for the qualitative and quantitative assessment of the aortic root. The coronary height will be assessed at baseline in relation to the aortic annulus and in relation to the stent of the bioprostheses after aortic valve replacement.
Sponsors
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 years; * Aortic valve stenosis or insufficiency with indication for elective aortic valve replacement with a bioprosthesis; * Possible concomitant coronary artery disease with indication for surgical or percutaneous revascularization; * CT imaging of the thorax with iodinated contrast agent carried out before surgery; * Signed informed consent, inclusive of release of medical information.
Exclusion criteria
* Aortic valve replacement in bicuspid valve or endocarditis; * Aortic valve replacement associated with surgery of ascending aorta/aortic root; * Aortic valve replacement associated with other cardiac valve surgery; * Previous cardiac surgery of any kind; * Patient unable to give informed consent or potentially noncompliant with the study protocol, in the judgment of the investigator; * Participation in another clinical trial that could interfere with the endpoints of this study; * Pregnant at time of screening; * Allergy or hypersensitivity to iodinated contrast agent; * End-stage renal disease on dialysis.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Coronary ostia height differences. | At least 90 days after surgery | Differences in coronary ostia height before and after surgical aortic valve replacement. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Coronary ostia height differences between different bioprostheses. | At least 90 days after surgery | Differences in coronary ostia height before and after surgical aortic valve replacement according to different bioprostheses used. |
Countries
Italy
Outcome results
None listed